Gregory J. Tsongalis, BS, MS, PhD
Title(s)
Emeritus Professor of Pathology and Laboratory Medicine
Additional Titles/Positions/Affiliations
Vice Chair for Research and
Director, Clinical Genomics and Advanced Technology (CGAT)
Department(s)
Pathology and Laboratory Medicine
Education
Univ. of Massachusetts, Amherst, BS, 1984
Quinnipiac College, MHS, 1986
Univ. of Medicine and Dentistry of New Jersey, PhD 1990
Uniiv. of North Carolina, Chapel Hill, post-doctoral 1990-1994
Programs
Dartmouth Cancer Center
Program in Experimental and Molecular Medicine
Websites
DHMC-CGAT.com
Contact Information
Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756
Office: WTRB 4th floor
Phone: 603-650-5498
Fax: 603-650-6120
Email: Gregory.J.Tsongalis@hitchcock.org
Assistant: Amber Erskine
Asst. Phone: 603-650-6821
Asst. Email: amber.j.erskine@hitchcock.org
Professional Interests
Development of advanced diagnostic technologies and disease biomarker discovery.
Grant Information
01/2014-12/30/15; Molecular profiling of tumor and ctDNA, riends of NCCC Scholar $50,000
03/01/13-01/31/2018; 1P20GM104416, Investigator / 2% COBRE Center for Molecular Epidemiology, Federal Direct Costs: $1,793,732
A novel adomavirus from proliferative skin lesions of a broadnose sevengill shark (Notorynchus cepedianus). On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study. Development of a multiplex ddPCR assay for simultaneous absolute quantification of bacterial, fungal, and human DNA. Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System. Novel Homozygous Full Gene Deletion of SLC12A5 in a Newborn With Refractory Seizures. A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial. Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center. Detection of Microsatellite Instability in Endometrial Carcinoma Using a Novel Homopolymer Assay. Simplifying SARS-CoV-2 wastewater-based surveillance using an automated FDA EUA assay. |
|